GenSight Biologics S.A. Current Assets

GenSight Biologics S.A. (GSGTF) currently reports a current assets of $4.2M as of June 2026. That compares with $2.7M in the prior-year period — up 53.1% year over year. Use the charts on this page to explore GenSight Biologics S.A.'s current assets history and peer comparisons.

GenSight Biologics S.A.'s current assets increased from $2.7M to $4.2M — a 53.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GenSight Biologics S.A. reported $4.2M in current assets as of June 2026. That compares with $2.7M in the prior-year period — up 53.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $4.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GenSight Biologics S.A., and consider following GSGTF for alerts when major investors trade the stock.

GenSight Biologics S.A. is classified in the Healthcare sector. On current assets, it currently shows $4.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GSGTF with unrelated industries.